Market research
BJDX Bluejay Diagnostics Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 928K
- P/E ratio
- Not available
- Analyst target
- 256
- Dividend yield
- Not available
- Beta
- 0.91
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US0956331039
- Market cap
- 928K
- P/E ratio
- Not available
- Analyst target
- 256
- Dividend yield
- Not available
- Beta
- 0.91
About
About Bluejay Diagnostics Inc
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Visit company websiteCommunity
Investor discussion
0 comments
Sign in to join the BJDX discussion.
No comments yet
Start a focused discussion about BJDX.